Table 1

Results of the questionnaire

QuestionsCorrect answers (%)Incorrect answers (%)Not sure (%)No answer (%)
*(T = true, F = false, NS = not sure. The correct answer, in bold, is in parentheses and following questions).
Section A: General questions about genital herpes 62 18 15 5
Q1: Genital herpes is the commonest cause of genital ulceration in developed countries (T-F-NS)*86410
Q2: Proportion of HSV–1 causing genital herpes is decreasing (T–F–NS)534412
Q3: GU medicine clinic attendees have higher prevalence of genital herpes than general population (T–F–NS)82990.5
Q4: Incidence of neonatal herpes in UK per 100 000 live births (<2–20–200)275617
Section B: Shedding, transmission, and clinical presentation 63 17 19 1
Q5: Majority of infected individuals with genital herpes are unaware of their infection (T–F–NS)572815
Q6: Source partners in most transmission events are unaware of their infection (T–F–NS)7311150.5
Q7: Patients shed the virus and transmit it even in absence of clinical signs (T–F–NS)778132
Q8: Most transmission occurs during periods of asymptomatic viral shedding (T–F–NS)4419361
Section C: Type specific serotesting of genital herpes 41 8 49 2
Q9: Positive serological test for HSV-2 essentially Indicates previous genital herpes infection (T–F–NS)489412
Q10: Serological testing can differentiate between HSV-1 and HSV-2 (T–F–NS)433513
Q11: Serological testing can differentiate between oral and genital HSV-1 infection (T–F–NS)3112542
Sections A + B: 63 17173
Sections A + B + C: 56 15 26 3
Section D: Attitude towards genital herpes serotesting:
Q12: Do you support the availability of this testing (at the present time) at least in GUM clinics? Yes No.Not sureNo answer
78%1.6%17.5%2.7%
Q13: Do you see this testing used in routine screening for STDs or in selected cases? Routine Selected casesNo answer
76%21%3%